Weiss, Markus
Wendel-Garcia, Pedro David
Grass, Beate
Kleine-Brueggeney, Maren
Funding for this research was provided by:
University of Zurich
Article History
Received: 30 January 2024
Accepted: 19 March 2024
First Online: 15 April 2024
Declarations
:
: Not applicable.
: MW serves as a consultant for medical device industries and has received consultant honoraria from BD. MW is cofounder of Silberspross GmbH Zurich, Switzerland, an innovation company advancing safety of intravenous drug therapy holding a patent on a new infusion access port. All other authors have no relevant financial or non-financial interests to disclose.